Extra-nodal natural killer/T cell lymphoma, nasal-type, treated by concurrent chemoradiotherapy
- Authors:
- Nobuhiko Yoshikawa
- Taisuke Inomata
- Taiju Shinbo
- Masatsugu Takahashi
- Yasuo Uesugi
- Yoshihumi Narumi
View Affiliations
Affiliations: Department of Radiology, Osaka Medical College, Osaka 569-8686, Japan. rad101@poh.osaka-med.ac.jp
- Published online on: May 1, 2010 https://doi.org/10.3892/etm_00000070
-
Pages:
453-455
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
The present study reports on a case of extra-nodal natural killer/T cell lymphoma, nasal-type (ENKL), stage IIEA, in a 50-year-old woman who presented with a white tumor on a refractory ulcer on the gum. Concurrent chemoradiotherapy was administered, and effected a partial response. However, tumor recurrence was observed 5 months after the final diagnosis, and the patient succumbed 1 month after recurrence. Although a definitive treatment for ENKL has yet to be established due to its rarity, radiation therapy (RT) is crucial to therapy, as ENKL is very sensitive to RT. However, treatment with radiation levels above 50 Gy with an extended RT field are required for a favorable outcome. The development of novel chemotherapy regimens may therefore be useful. Additionally, autologous or allogenic hematopoietic stem-cell transplantation may prove to be a promising approach.
View References
|
1.
|
Yamaguchi M, Tobinai K, Oguchi M, et al:
Phase I/II Study of Concurrent Chemoradiotherapy for Localized
Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group
Study JCOG0211. J Clin Oncol. 27:5594–6001. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Lymphoma Study Group of Japanese
Pathologists: The World Health Organization classification of
malignant lymphomas in Japan: incidence of recently recognized
entities. Pathol Int. 50:696–702. 2000. View Article : Google Scholar
|
|
3.
|
Yamaguchi M, Ogawa S, Nomoto Y, et al:
Treatment outcome of nasal NK-T cell lymphoma: a report of 12
consecutively-diagnosed cases and a review of the literature. J
Clin Exp Hematopathol. 41:93–99. 2001. View Article : Google Scholar
|
|
4.
|
Cheung MMC, Chan JKC, Lau WH, Ngan RKC and
Foo WWL: Early stage nasal T/NK-cell lymphoma: clinical outcome,
prognostic factors, and the effect of treatment modality. Int J
Radiat Oncol Biol Phys. 54:182–190. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Isobe K, Uno T, Tamaru J, et al:
Extranodal natural killer/T-cell lymphoma, nasal type. Cancer.
106:609–615. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Kim K, Chie EK, Kim CW, Kim IH and Park
CI: Treatment outcome of angiocentric T-cell and NK/T-cell
lymphoma, nasal type: radiotherapy versus chemoradiotherapy. Jpn J
Clin Oncol. 35:1–5. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Suzuki R, Takeuchi K, Ohshima K and
Nakamura S: Extranodal NK/T-cell lymphoma: diagnosis and treatment
cues. Hematol Oncol. 26:66–72. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Shikama N, Ikeda H, Nakamura S, et al:
Localized aggressive non-Hodgkin’s lymphoma of the nasal cavity: a
survey by the Japan Lymphoma Radiation Therapy Group. Int J Radiat
Oncol Biol Phys. 51:1228–1233. 2001.
|
|
9.
|
Koom W, Chung E, Yang W, et al:
Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic
viewpoints. Int J Radiat Oncol Biol Phys. 59:1127–1137. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Yamaguchi M, Suzuki R, Kwong YL, et al:
Phase I study of dexamethasone, methotrexate, ifosfamide,
L-asparaginase, and etoposide (SMILE) chemotherapy for
advanced-stage, relapsed or refractory extranodal natural killer
(NK)/T-cell lymphoma and leukemia. Cancer Sci. 99:1016–1020. 2008.
View Article : Google Scholar
|
|
11.
|
Egashira M, Kawamata N, Sugimoto K, Kaneko
T and Oshimi K: P-glycoprotein expression on normal and abnormally
expanded natural killer and inhibition of P-glycoprotein function
by cyclosporine A and its analogue, P SC83. Blood. 93:599–606.
1999.PubMed/NCBI
|
